
Century Therapeutics, Inc.
NASDAQ:IPSC
0.55 (USD) • At close May 2, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Century Therapeutics, Inc. |
Symbool | IPSC |
Munteenheid | USD |
Prijs | 0.55 |
Beurswaarde | 47,387,340 |
Dividendpercentage | 0% |
52-weken bereik | 0.342 - 3.7 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Gregory Russotti Ph.D. |
Website | https://www.centurytx.com |
An error occurred while fetching data.
Over Century Therapeutics, Inc.
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)